Risk factors for treatment failure in osteoporotic patients with rheumatoid arthritis
- 3 August 2015
- journal article
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 26 (2) , 194-199
Abstract
No available anti-osteoporotic medication has been shown to completely prevent declines in bone mineral density (BMD) and the resulting increased risk of fracture. The objective of this study was to investigate the risk factors for treatment failure in osteoporotic patients with rheumatoid arthritis (RA). A retrospective cohort study of 103 patients with RA and osteoporosis was conducted. Patients were divided into two groups for comparison: those whose osteoporosis treatment was effective and those whose treatment failed. Risk factors for treatment failure were identified by univariate and multivariate logistic regression using variables that differed significantly between the groups. Osteoporosis treatment failed in 66 of 103 patients (64.1%). During 14.01 months of follow-up, non-adherence to bisphosphonate use was the most powerful risk factor for treatment failure. Daily glucocorticoid dosage ≥ 7.5 mg/day before the first BMD measurement, immobilization > 3 months, and Disease Activity Score in 28 joints (DAS28) ≥ 3.2 were also significantly related to treatment failure. Our findings indicate that osteoporosis treatment fails frequently in RA patients and adherence to bisphosphonate use, daily glucocorticoid dosage, immobilization, and DAS28 score should be taken into consideration when treating osteoporotic patients with RA.Keywords
This publication has 35 references indexed in Scilit:
- Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)Journal of Bone and Mineral Research, 2013
- Treatment failure in osteoporosisOsteoporosis International, 2012
- Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone ClubOsteoporosis International, 2010
- Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)QJM: An International Journal of Medicine, 2006
- Identification of vertebral fractures: An updateOsteoporosis International, 2005
- Nonresponders to Osteoporosis TherapyJournal of Clinical Densitometry, 2003
- Diagnosis of osteoporosis and assessment of fracture riskThe Lancet, 2002
- Treatment of postmenopausal osteoporosisThe Lancet, 2002
- Risk of Mortality Following Clinical FracturesOsteoporosis International, 2000
- BONE MASS MEASUREMENT AND BONE METABOLISM IN RHEUMATOID ARTHRITIS: A REVIEWRheumatology, 1996